Francesca Zammarchi
5PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 18, 2025
Lineage dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and -independent immunotherapeutic targets.Nathan M Kendsersky, Michal Odrobina, Nathaniel W Mabe
|Feb 07, 2024
ADCT-602, a Novel PBD Dimer-containing Antibody-Drug Conjugate for Treating CD22-positive Hematologic Malignancies.Francesca Zammarchi, Karin E Havenith, Nikoleta Sachini
|Dec 18, 2023
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma.Amber K Weiner, Alexander B Radaoui, Matthew Tsang
|Jan 28, 2022
Preclinical Development of ADCT-601, a Novel Pyrrolobenzodiazepine Dimer-based Antibody-drug Conjugate Targeting AXL-expressing Cancers.Francesca Zammarchi, Karin Eg Havenith, Simon Chivers
|Sep 11, 2020
CD25-targeted antibody-drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity.Francesca Zammarchi, Karin Havenith, Francois Bertelli
Pageof 1
Frequent Collaborators
2 joint publications
John M Maris
1 joint publications
Halla W Reinert
1 joint publications
Amber K Weiner
1 joint publications
Simone Sidoli
1 joint publications
Karina L Conkrite
1 joint publications
Alberto Delaidelli
1 joint publications
Apexa Modi
1 joint publications
Jo Lynne Rokita
1 joint publications
Khushbu Patel
1 joint publications
Maria V Lane
